Fidson Healthcare Plc (NGX:FIDSON)
Nigeria · Delayed Price · Currency is NGN 136.50
0.00 (0.00%)
At close: May 22, 2026
Fidson Healthcare Income Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 126,647 | 119,061 | 84,189 | 53,050 | 40,634 | 30,861 | |
Revenue Growth (YoY) | 26.24% | 41.42% | 58.70% | 30.56% | 31.67% | 68.86% |
Cost of Revenue | 74,192 | 71,649 | 49,731 | 32,260 | 23,667 | 16,061 |
Gross Profit | 52,455 | 47,412 | 34,458 | 20,790 | 16,967 | 14,800 |
Selling, General & Admin | 24,191 | 20,206 | 16,186 | 11,802 | 9,583 | 9,534 |
Other Operating Expenses | -846.25 | -865.05 | -610.97 | -488.78 | -783.26 | -513.29 |
Operating Expenses | 23,158 | 19,354 | 15,518 | 11,541 | 8,754 | 9,021 |
Operating Income | 29,297 | 28,058 | 18,940 | 9,249 | 8,213 | 5,779 |
Interest Expense | -6,811 | -7,130 | -5,494 | -2,102 | -1,773 | -1,222 |
Interest & Investment Income | 119 | 144.32 | 60.02 | 23.01 | 65.42 | 77.72 |
Currency Exchange Gain (Loss) | -5,590 | -6,012 | -5,449 | -1,261 | -758.6 | - |
Other Non Operating Income (Expenses) | -120.13 | -120.13 | -357.79 | - | - | - |
EBT Excluding Unusual Items | 16,895 | 14,940 | 7,700 | 5,909 | 5,747 | 4,634 |
Gain (Loss) on Sale of Assets | 22.5 | 22.5 | 0.91 | 8.29 | 34.23 | 83.26 |
Pretax Income | 16,917 | 14,963 | 7,700 | 5,917 | 5,781 | 4,718 |
Income Tax Expense | 5,724 | 5,079 | 3,301 | 2,310 | 1,594 | 997.73 |
Net Income | 11,193 | 9,884 | 4,399 | 3,608 | 4,187 | 3,720 |
Net Income to Common | 11,193 | 9,884 | 4,399 | 3,608 | 4,187 | 3,720 |
Net Income Growth | 69.27% | 124.68% | 21.94% | -13.84% | 12.56% | 208.70% |
Shares Outstanding (Basic) | 2,428 | 2,400 | 2,295 | 2,295 | 2,295 | 2,295 |
Shares Outstanding (Diluted) | 2,428 | 2,400 | 2,295 | 2,295 | 2,295 | 2,295 |
Shares Change (YoY) | 5.96% | 4.58% | - | - | - | - |
EPS (Basic) | 4.61 | 4.12 | 1.92 | 1.57 | 1.82 | 1.62 |
EPS (Diluted) | 4.61 | 4.12 | 1.92 | 1.57 | 1.82 | 1.62 |
EPS Growth | 59.75% | 114.85% | 21.94% | -13.84% | 12.56% | 208.70% |
Free Cash Flow | 15,781 | 8,804 | -4,342 | -2,898 | -2,873 | 2,234 |
Free Cash Flow Per Share | 6.50 | 3.67 | -1.89 | -1.26 | -1.25 | 0.97 |
Dividend Per Share | 1.500 | 1.500 | 1.000 | 0.600 | 0.550 | 0.455 |
Dividend Growth | 50.00% | 50.00% | 66.67% | 9.09% | 21.01% | 99.96% |
Gross Margin | 41.42% | 39.82% | 40.93% | 39.19% | 41.76% | 47.96% |
Operating Margin | 23.13% | 23.57% | 22.50% | 17.44% | 20.21% | 18.73% |
Profit Margin | 8.84% | 8.30% | 5.22% | 6.80% | 10.30% | 12.05% |
Free Cash Flow Margin | 12.46% | 7.40% | -5.16% | -5.46% | -7.07% | 7.24% |
EBITDA | 31,727 | 30,297 | 20,572 | 10,458 | 9,110 | 6,474 |
EBITDA Margin | 25.05% | 25.45% | 24.44% | 19.71% | 22.42% | 20.98% |
D&A For EBITDA | 2,430 | 2,239 | 1,632 | 1,209 | 897.42 | 695.39 |
EBIT | 29,297 | 28,058 | 18,940 | 9,249 | 8,213 | 5,779 |
EBIT Margin | 23.13% | 23.57% | 22.50% | 17.44% | 20.21% | 18.73% |
Effective Tax Rate | 33.84% | 33.95% | 42.87% | 39.03% | 27.58% | 21.15% |
Advertising Expenses | - | 1,424 | 626.93 | 1,183 | 1,400 | 663.26 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.